Pfizer will only deliver half the vaccines it expected to this year


Pfizer Inc. will only be able to deliver half the COVID-19 vaccine doses it promised to ship by the end of the year, the company said Thursday.
Pfizer and its German partner BioNTech SE projected it would distribute 100 million vaccines worldwide in 2020, but has cut that to 50 million. "Scaling up the raw material supply chain took longer than expected," a spokesperson told The Wall Street Journal, and the vaccine's clinical trial finished "somewhat later than the initial projection" as well. A person directly involved in the vaccine's development meanwhile said "some early batch of raw material failed to meet the standards," leading Pfizer to miss this year's projections.
The U.K. on Wednesday granted an emergency-use authorization for Pfizer's two-shot vaccine, making it the first Western country to do so. The U.S. Food and Drug Administration is reviewing Pfizer's vaccine for a similar authorization after it proved safe and effective at stopping the transmission of COVID-19.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
America's favorite fast food restaurants
The Explainer There are different ways of thinking about how Americans define how they most like to spend their money on burgers, tacos and fried chicken
-
Law: The battle over birthright citizenship
Feature Trump shifts his focus to nationwide injunctions after federal judges block his attempt to end birthright citizenship
-
The threat to the NIH
Feature The Trump administration plans drastic cuts to medical research. What are the ramifications?
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County